Matches in SemOpenAlex for { <https://semopenalex.org/work/W2599547605> ?p ?o ?g. }
- W2599547605 endingPage "309" @default.
- W2599547605 startingPage "300" @default.
- W2599547605 abstract "Metastasis impedes the successful chemotherapy for breast cancer. In this study, an Akt inhibitor (quercetin, Qu) was co-delivered with a chemotherapeutic agent (docetaxel, DTX) by using hyaluronic acid (HA)-modified nanoparticles (NPs) as vectors to block metastasis. Dual DTX/Qu-loaded HA/polylactic-co-glycolic acid–polyethyleneimine NPs (PP-HA/NPs) were prepared through a modified emulsion solvent evaporation technique. The particle size of PP-HA/NPs with narrow polydispersity was 209.8 ± 10.8 nm. Wound healing assay revealed that Qu co-delivery and HA modification elicited synergistic inhibitory effects on cell motility. The downregulation of p-Akt and matrix metalloproteinase-9 (MMP-9) expression contributed to the significant inhibition of cell migration and invasion with inhibition rates of 95.6% and 99.3%, respectively. Further studies indicated that PP-HA/NPs could be efficiently uptaken by 4T1 breast cancer cells and could further induce cytotoxicity, decrease colony formation and promote cell apoptosis. Biodistribution assay demonstrated PP-HA/NPs also enhanced drug accumulation in the tumor and lungs and predicted that PP-HA/NPs could be employed as an effective therapy for primary tumor and pulmonary metastasis. Therefore, PP-HA/NPs could be a promising delivery system to treat metastatic breast cancer effectively." @default.
- W2599547605 created "2017-04-07" @default.
- W2599547605 creator A5000766273 @default.
- W2599547605 creator A5007436852 @default.
- W2599547605 creator A5013396581 @default.
- W2599547605 creator A5016525428 @default.
- W2599547605 creator A5071672663 @default.
- W2599547605 creator A5079691548 @default.
- W2599547605 creator A5079914267 @default.
- W2599547605 date "2017-05-01" @default.
- W2599547605 modified "2023-10-05" @default.
- W2599547605 title "Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway" @default.
- W2599547605 cites W1967700449 @default.
- W2599547605 cites W1971948817 @default.
- W2599547605 cites W1972132727 @default.
- W2599547605 cites W1972287875 @default.
- W2599547605 cites W1973804879 @default.
- W2599547605 cites W1975587250 @default.
- W2599547605 cites W1978708377 @default.
- W2599547605 cites W1985538444 @default.
- W2599547605 cites W1989839281 @default.
- W2599547605 cites W1991988965 @default.
- W2599547605 cites W1996051333 @default.
- W2599547605 cites W2000957918 @default.
- W2599547605 cites W2005113904 @default.
- W2599547605 cites W2006250811 @default.
- W2599547605 cites W2017560192 @default.
- W2599547605 cites W2018622636 @default.
- W2599547605 cites W2033019399 @default.
- W2599547605 cites W2036460370 @default.
- W2599547605 cites W2037632318 @default.
- W2599547605 cites W2043502463 @default.
- W2599547605 cites W2053623902 @default.
- W2599547605 cites W2054757669 @default.
- W2599547605 cites W2055785743 @default.
- W2599547605 cites W2068245790 @default.
- W2599547605 cites W2071090693 @default.
- W2599547605 cites W2075521812 @default.
- W2599547605 cites W2076583198 @default.
- W2599547605 cites W2081571363 @default.
- W2599547605 cites W2082382893 @default.
- W2599547605 cites W2083497653 @default.
- W2599547605 cites W2087470472 @default.
- W2599547605 cites W2092830423 @default.
- W2599547605 cites W2095019580 @default.
- W2599547605 cites W2107464496 @default.
- W2599547605 cites W2107577958 @default.
- W2599547605 cites W2112327424 @default.
- W2599547605 cites W2115062156 @default.
- W2599547605 cites W2115280618 @default.
- W2599547605 cites W2126647999 @default.
- W2599547605 cites W2127624074 @default.
- W2599547605 cites W2134410622 @default.
- W2599547605 cites W2143762419 @default.
- W2599547605 cites W2150416060 @default.
- W2599547605 cites W2155464400 @default.
- W2599547605 cites W2162962263 @default.
- W2599547605 cites W2162966642 @default.
- W2599547605 cites W2163180789 @default.
- W2599547605 cites W2166641563 @default.
- W2599547605 cites W2168661387 @default.
- W2599547605 cites W2185943375 @default.
- W2599547605 cites W2190570130 @default.
- W2599547605 cites W2272216542 @default.
- W2599547605 cites W2295763130 @default.
- W2599547605 cites W2321961859 @default.
- W2599547605 cites W2341363697 @default.
- W2599547605 doi "https://doi.org/10.1016/j.ijpharm.2017.03.040" @default.
- W2599547605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28336457" @default.
- W2599547605 hasPublicationYear "2017" @default.
- W2599547605 type Work @default.
- W2599547605 sameAs 2599547605 @default.
- W2599547605 citedByCount "60" @default.
- W2599547605 countsByYear W25995476052017 @default.
- W2599547605 countsByYear W25995476052018 @default.
- W2599547605 countsByYear W25995476052019 @default.
- W2599547605 countsByYear W25995476052020 @default.
- W2599547605 countsByYear W25995476052021 @default.
- W2599547605 countsByYear W25995476052022 @default.
- W2599547605 countsByYear W25995476052023 @default.
- W2599547605 crossrefType "journal-article" @default.
- W2599547605 hasAuthorship W2599547605A5000766273 @default.
- W2599547605 hasAuthorship W2599547605A5007436852 @default.
- W2599547605 hasAuthorship W2599547605A5013396581 @default.
- W2599547605 hasAuthorship W2599547605A5016525428 @default.
- W2599547605 hasAuthorship W2599547605A5071672663 @default.
- W2599547605 hasAuthorship W2599547605A5079691548 @default.
- W2599547605 hasAuthorship W2599547605A5079914267 @default.
- W2599547605 hasConcept C105702510 @default.
- W2599547605 hasConcept C109316439 @default.
- W2599547605 hasConcept C121608353 @default.
- W2599547605 hasConcept C126322002 @default.
- W2599547605 hasConcept C178790620 @default.
- W2599547605 hasConcept C185592680 @default.
- W2599547605 hasConcept C190283241 @default.
- W2599547605 hasConcept C202751555 @default.
- W2599547605 hasConcept C2777529286 @default.
- W2599547605 hasConcept C2779013556 @default.